Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

74.24
+2.483.46%
Post-market: 74.08-0.1555-0.21%17:55 EDT
Volume:711.97K
Turnover:52.68M
Market Cap:3.26B
PE:-68.59
High:74.94
Open:71.47
Low:70.71
Close:71.76
52wk High:85.25
52wk Low:48.20
Shares:43.88M
Float Shares:32.68M
Volume Ratio:1.16
T/O Rate:2.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.40
PE(LYR):-46.69

Loading ...

Tarsus Pharmaceuticals (TARS) Shares Just Moved, What Is Behind The Attention?

Simply Wall St.
·
Aug 18

Tarsus Pharmaceuticals Price Target Raised to $100.00/Share from $97.00 by Oppenheimer

Dow Jones
·
Aug 12

Oppenheimer Adjusts PT on Tarsus Pharmaceuticals to $100 From $97, Keeps Outperform Rating

MT Newswires Live
·
Aug 12

Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus

Simply Wall St.
·
Aug 09

Mizuho Adjusts Tarsus Pharmaceuticals PT to $100 From $98, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

Tarsus Pharmaceuticals Balances XDEMVY Surge With Retina Bet

TIPRANKS
·
Aug 07

Tarsus Pharmaceuticals Q2 EPS $(0.43) Misses $(0.20) Estimate, Sales $173.912M Beat $169.677M Estimate

Benzinga Earnings
·
Aug 07

Verrica Pharma Reports Wider-than-Expected Q2 Adj Loss Per Share

Reuters
·
Aug 07

Tarsus Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Tarsus Pharmaceuticals announces $125M private placement

TIPRANKS
·
Aug 06

Tarsus Pharmaceuticals Q2 Sales Beat Estimates, Lifts 2026 Xdemvy Sales Outlook

Reuters
·
Aug 06

Tarsus to Buy Alkeus in Deal Worth About $450 Million Upfront

Reuters
·
Aug 06

Tarsus Prices USD 125 Million PIPE at USD 56 Per Share

Reuters
·
Aug 06

Tarsus Q2 FY26 Net Loss Narrows 8.77% to $18.55 Million; Net Product Sales Rise More than 69% to $173.91 Million

Reuters
·
Aug 06

Tarsus Pharmaceuticals Q2 EPS USD -0.43

THOMSON REUTERS
·
Aug 06

Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth

THOMSON REUTERS
·
Aug 06

Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

THOMSON REUTERS
·
Aug 06

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position

THOMSON REUTERS
·
Aug 06

Tarsus Pharmaceuticals, - up to $350 Mln in Milestone Payments upon Regulatory Approval and First Sale

THOMSON REUTERS
·
Aug 06

Tarsus Pharmaceuticals, - Deal Includes $450 Mln Upfront, $270 Mln Cash, $180 Mln in Tarsus Stock

THOMSON REUTERS
·
Aug 06